Welltower (WELL)
Real Estate · Healthcare REIT · NYSE
Welltower is a premier healthcare real estate investment trust providing the infrastructure for the aging population's care needs through its extensive portfolio of seniors housing and post-acute facilities.
What Welltower does
Welltower is a real estate investment trust (REIT) that invests in healthcare infrastructure, specifically focusing on seniors housing, post-acute care, and outpatient medical properties. The company operates through a portfolio of properties that are managed by third-party operators or through RIDEA-structured arrangements, providing a range of care levels from independent living to skilled nursing. Welltower's business model relies on the ongoing demand for healthcare services for the aging population and the associated real estate requirements.
Themes: seniors housing, healthcare infrastructure, aging population, assisted living, post-acute care, outpatient medical
Fundamentals
- Price$223.04 as of 2026-10-08 close
- Market cap$157.4B as of 2026-04-24 (share count; price 2026-10-08)
- 1-year return+31.9% 2025-10-08 close $169.14 → 2026-10-08 close $223.04
- P/E103.48 as of 2026-10-08
- Net margin+8.9% FY2025, SEC XBRL
- ROE+2.2% FY2025, SEC XBRL
- Debt / equity0.38 as of 2026-09-02
- Revenue growth (YoY)+37.6% as of 2026-09-02
- Revenue CAGR (3y)+22.7% SEC XBRL
- Beta0.25 as of 2026-09-02
- Last reported earnings2026-07-27 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +1.5%; 5-year non-decreasing per-share dividend streak (SEC XBRL).
How WELL compares in its sector
- price-to-earnings ratiotop 25% 120 covered Real Estate peers, as of 2026-10-08
- net profit marginmiddle range 154 covered Real Estate peers, as of 2026-09-02
- return on equitymiddle range 158 covered Real Estate peers, as of 2026-09-02
- 3-year revenue CAGRtop 10% 155 covered Real Estate peers
- indicated dividend yieldbottom 10% 140 covered Real Estate peers, as of 2026-09-02
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
WELL is not currently in any published Top 10 list. Its scores are below.
Top 10 score
53.6 #540 of 1,379 scored · #16 of 87 in Real Estate
Growth 89th (revenue growth year over year 37.6%, 3-year revenue CAGR 22.7%) and trend 73rd (a "golden cross" — its 50-day average is above its 200-day); weakest is profitability (21st, return on equity 2.2%).
Scores as of 8 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Dividend coverage (FY2025)
Exceeded at least one reported measure. In FY2025, WELL's dividend exceeded at least one reported measure of what it earned or generated (earnings payout 195%, operating-cash-flow payout 65%). A payout above 100% in one year is not necessarily unsustainable, but it is not fully covered by that measure.
- Earnings payout195% dividends / net income
- Operating-cash-flow payout65% dividends / operating cash flow — capital spending was not reported, so this does not subtract it
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Welltower looks technically
Welltower (WELL) is trading 4.1% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 892 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 14, below the 25 that marks a real trend), though sellers have been pushing harder than buyers lately — pressure, not a trend. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 37, neither overbought (above 70) nor oversold (below 30). It made a new 20-day low about 2 trading days ago.
Trend
8
| Distance from the 200-day | it is trading 4.1% above its 200-day average, the long-term trend line — a longer-term uptrend | +4.1% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $233.84 | $233.84 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $214.32 | $214.32 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 20 calendar days ago — the swings before that are what the structure reading is measured on | 20 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that downward direction; the labelling fails if price closes above 224.97. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible downward five-wave sequence, in wave 4 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 892 trading days ago — a "golden cross", a bullish long-term signal | 892 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 14, below the 25 that marks a real trend), though sellers have been pushing harder than buyers lately — pressure, not a trend | 14.4 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 37, neither overbought (above 70) nor oversold (below 30) | 37.2 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($220.00 to $237.32) — its "stochastic" reading is 18 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 17.6 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 24 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $255.20 | $255.20 |
|---|---|---|
| From the 52-week high | it is 12.6% below its 52-week high (its highest price of the past year) | -12.6% |
| Above the 52-week low | it is 36.2% above its 52-week low (its lowest price of the past year) | +36.2% |
| Below the 52-week high | it is 12.6% below its highest point of the past year | 12.6% |
| Since a 20-day breakout | it made a new 20-day low about 2 trading days ago | 2 sessions |
| Since a 55-day breakout | it made a new 55-day low about 2 trading days ago | 2 sessions |
| All-time high | its highest closing price on record is $255.20 (set on 2026-07-28) | $255.20 |
| Given back of the 52-week move | over the past year its closes ranged ($165.94 to $252.07), and it has given back roughly a third of its rise from last year’s low — 34% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $196.09 to $198.84. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 33.7% |
| From the all-time high | it is 12.6% below its all-time high | -12.6% |
| Nearest price level | it is trading 1.1% above a support level at $220.63 — a price it turned at twice since 2026-04-29, most recently on 2026-05-13. Since 2024-10-08 it has 15 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -1.1% |
| All-time low | its lowest closing price on record is $24.27 (set on 2020-03-18) | $24.27 |
| Above the all-time low | it is 819.0% above its all-time low | +819.0% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 31st percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $4.92 between its high and its low — about 2.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $4.92 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $222.09 and $238.02 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $222.09 – $230.05 – $238.02 |
| Typical daily range (% of price) | its price moves about 2.2% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.2% |
| Stretch from the 200-day average | it is trading 1.8 daily ranges above its 200-day average price (4.1% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.8 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.89× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a bearish engulfing | 1 session ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 1 session ago |
|---|
Price gaps
1
| Gap at the open | it opened on 2026-10-08 at essentially the same price it closed at the session before — no meaningful overnight gap | 0.0% |
|---|
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 7.0 percentage points (the stock lost 6.0% while the market gained 1.0%) | -7.0% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 8.5 percentage points (the stock lost 4.6% while the market gained 3.8%) | -8.5% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 6.4 percentage points (the stock gained 11.0% while the market gained 17.5%) | -6.4% |
| vs market, 12 months | over the past 12 months this stock beat the market by 16.9 percentage points (the stock gained 31.9% while the market gained 15.0%) | +16.9% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bearish state: a fresh 20-day low, MACD momentum is negative, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 2.6% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 4.5% of the share price. | -2.6% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 4% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $215.43 — a volume-weighted average of daily closes over 188 sessions, not a true tick-by-tick VWAP. | +3.5% |
|---|---|---|
| Vs the average paid since it last reported | the price is 5% below the average price paid since it last reported on 2026-07-27 (its 8-K), so the typical buyer over that stretch is under water. That average is $234.26 — a volume-weighted average of daily closes over 53 sessions, not a true tick-by-tick VWAP. | -4.8% |
Price levels it has turned at before
WELL last closed at $223.04 on 2026-10-08. Since 2024-10-08 it has turned at 15 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $220.63 | Support | 1.1% below the last close | turned there twice · 2026-04-29 to 2026-05-13 |
| $227.11 | Resistance | 1.8% above the last close | turned there three times · 2026-07-10 to 2026-09-18 |
| $215.32 | Support | 3.5% below the last close | turned there three times · 2026-02-17 to 2026-04-17 |
| $209.83 | Support | 5.9% below the last close | turned there three times · 2025-11-28 to 2026-05-18 |
| $238.22 | Resistance | 6.8% above the last close | turned there twice · 2026-07-07 to 2026-09-25 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes above $224.97.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
On past moves of this shape the leg has usually ended somewhere between $224.97 and $231.55 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 2 trading days, since 2026-10-07.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Broke down to a new 20-day low · trendless / choppy (low ADX) · lagging the market · At the bottom of its 14-day range (stochastic below 20) · Under water since its last earnings report (below the anchored VWAP) | Learn: moving average · golden cross · adx · rsi · breakout
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.64 mean, 1=Strong Buy…5=Strong Sell) — 22 analysts
- Mean price target$262.05 range $219.00 – $292.00; median $262.50
Analyst estimates, as of 2026-10-07. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for WELL
- Consensus EPS estimate$0.625 next reporting period, as of 2026-10-07
- Estimate change, 30 days$0.00 (0.0%) from $0.625, on 2026-09-02, 35-day window
- Readings revised upward13% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Regulatory risks related to state licensing, certificate of need (CON) laws, and potential changes in government reimbursement methodologies (Medicare/Medicaid).","Dependence on the financial health and operational success of third-party property operators.","Potential for decreased demand or increased competition in the healthcare facility market, affecting property values and occupancy rates."]
What changed in the latest 10-Q
AI-assisted comparison of WELL's 10-Q filed 2026-04-29 against the prior one filed 2025-10-28.
Management's Discussion & Analysis (MD&A)
- Added:
- Added reference to 'geopolitical tensions or conflicts, such as the ongoing conflict between Russia and Ukraine and in the Middle East' as a forward-looking statement risk factor (filed 2026-04-29)
- Removed:
- Removed specific reference to 'COVID-19 pandemic' example in health emergencies risk factor; now states generic 'public health emergencies' (filed 2025-10-28 had this specificity)
- Reworded:
- Changed 'health emergencies (such as the COVID-19 pandemic)' to 'public health emergencies' (filed 2026-04-29)
- Changed reference document from 'Annual Report on Form 10-K for the year ended December 31, 2024' to 'Annual Report on Form 10-K for the year ended December 31, 2025' (filed 2026-04-29)
- Changed 'our consolidated financial statements' to 'our unaudited consolidated financial statements' (filed 2026-04-29)
- Changed 'Pounds Sterling' to 'British Pounds Sterling' (filed 2026-04-29)
- Changed 'is reflected at fair value' to 'are reflected at fair value' (filed 2026-04-29)
- Changed 'the United Kingdom' to 'the U.K.' (filed 2026-04-29)
- Notes:
- The newer filing shows updated financial data tables with dates changed from September 30, 2025 and December 31, 2024 to March 31, 2026 and December 31, 2025, with corresponding updated principal balances and fair value figures
- Variable rate debt amounts changed from $2,055,045,000 (Sept 30, 2025) to $2,866,865,000 (March 31, 2026)
- The text in both filings appears truncated at the end, preventing full comparison of the currency fluctuation discussion section
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
4 open-market purchases and 0 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 90 days · read to 2026-10-044 buys ($2M) · 0 sells — 1 buying insider
- Last 180 days · read to 2026-10-044 buys ($2M) · 0 sells — 1 buying insider
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-26. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about WELL's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 2 matched disclosures for WELL from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Short interest (FINRA)
WELL had 17,596,292 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
WELL had 2.49% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 7.56 days to cover at the same settlement.
- Reported short interest (shares) 17,596,292
- Short interest (% of shares outstanding) 2.49%
- Prior settlement (shares) 18,431,638
- Reported change -4.53%
- Days to cover (reported) 7.56
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Ventas (VTR)
- Healthpeak Properties
- Sabra Health Care REIT (SBRA)
- Omega Healthcare Investors (OHI)
- National Health Investors (NHI)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare WELL vs…
Welltower is found in…
WELL shows up in…
Frequently asked questions
What does Welltower (WELL) do?
Welltower is a real estate investment trust (REIT) that invests in healthcare infrastructure, specifically focusing on seniors housing, post-acute care, and outpatient medical properties. The company operates through a portfolio of properties that are managed by third-party operators or through RIDEA-structured arrangements, providing a range of care levels from independent living to skilled nursing.
What sector is Welltower (WELL) in?
Welltower (WELL) is classified in the Real Estate sector. Its industry is Healthcare REIT. It trades on NYSE.
Does WELL pay a dividend?
Yes — Welltower (WELL) pays a dividend, with an indicated yield of about 1.49% and 5-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-09-02). Informational only — not financial advice.
Who are Welltower's (WELL) competitors?
Notable peers of Welltower (WELL) include Ventas, Healthpeak Properties, Sabra Health Care REIT, Omega Healthcare Investors and National Health Investors. This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in WELL?
Yes — we hold 2 matched STOCK Act disclosures for WELL from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Welltower (WELL) overbought or oversold right now?
Welltower (WELL) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 37, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on WELL come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.